Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Liabilities (2016 - 2023)

Wave Life Sciences' Other Non-Current Liabilities history spans 9 years, with the latest figure at $190000.0 for Q2 2023.

  • For Q2 2023, Other Non-Current Liabilities changed N/A year-over-year to $190000.0; the TTM value through Jun 2023 reached $190000.0, changed N/A, while the annual FY2022 figure was $190000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $190000.0 in Q2 2023 per WVE's latest filing, roughly flat from $190000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q1 2019 to a low of $190000.0 in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $1.0 million, with a median of $1.0 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: surged 113.27% in 2022, then tumbled 78.11% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.7 million in 2019, then crashed by 72.46% to $474000.0 in 2020, then skyrocketed by 113.92% to $1.0 million in 2021, then tumbled by 81.26% to $190000.0 in 2022, then changed by 0.0% to $190000.0 in 2023.
  • Per Business Quant, the three most recent readings for WVE's Other Non-Current Liabilities are $190000.0 (Q2 2023), $190000.0 (Q1 2023), and $190000.0 (Q4 2022).